STEX Partners with Chainlink: A Game-Changer for Tokenization!

Overview of Streamex (STEX) and Chainlink Partnership

Streamex Corp. (NASDAQ: STEX) – recently rebranded from BioSig Technologies – is a real-world asset tokenization company focused on bringing commodities like gold on-chain through regulated, yield-bearing digital assets (^[1]) (^[2]). Its flagship product is GLDY, a gold-backed stablecoin designed to deliver institutional-grade cash management and yield on physical gold holdings (^[3]) (^[3]). In October 2025, Streamex announced a strategic partnership with Chainlink, a leading blockchain oracle provider, to enhance transparency and cross-chain operability for GLDY (^[3]) (^[4]). Chainlink’s Proof of Reserve and price oracles will provide real-time on-chain verification of Streamex’s gold reserves, while Chainlink’s Cross-Chain Interoperability Protocol (CCIP) enables seamless transfer of GLDY across multiple blockchains (^[4]). This integration is a potential game-changer for Streamex – it bolsters investor trust in the 1:1 gold backing of GLDY and expands its reach beyond a single network, addressing two key hurdles in asset tokenization (trust and liquidity). Streamex’s CEO Henry McPhie heralded the Chainlink integration as “a major step forward” in bringing real assets on-chain with the transparency and reliability needed for institutional adoption (^[4]).

Streamex’s business model is vertically integrated: the company maintains a gold-denominated balance sheet and pursues novel financing structures to generate yield from physical commodities (^[4]). Its initial strategy resembles a mining streaming/royalty model – Streamex provides upfront funding to gold producers in exchange for rights to future gold output, then tokenizes those delivery rights for investors (^[5]). The resulting GLDY tokens are fully backed by physical gold in accredited vaults and are designed to pay an annual yield (in gold) around 4% to token holders (^[6]). In essence, Streamex is aiming to reinvent commodity finance: using blockchain tokens to make streams of gold production tradable and liquid, with Chainlink’s infrastructure ensuring on-chain proof-of-reserves and cross-chain accessibility. The recent Chainlink partnership reinforces Streamex’s positioning as an institutional-grade tokenization platform, which could help attract the large investors needed to scale its model (^[4]). Going forward, the company has signaled ambitions beyond just gold – for example, it signed a letter of intent with Simplify Asset Management (a $10B AUM ETF issuer) to explore integrating tokenized gold-yield assets into traditional ETFs (^[1]). This points to a broader vision where Streamex’s technology could be applied to financial products in mainstream markets, though concrete developments on that front remain upcoming.

Dividend Policy and Yield

As a newly launched growth company, Streamex does not currently pay any dividend on its common stock (^[7]). There is no dividend history to speak of, and the stock’s dividend yield stands at 0%. This policy is unsurprising given Streamex’s early-stage status and need to reinvest capital – management’s focus is on building out its tokenization platform and funding asset purchases (like gold bullion) rather than returning cash to shareholders. Traditional REIT metrics like FFO or AFFO are not applicable here, since Streamex is not a real estate operator and has virtually no operating cash flows yet. Instead, the “yield” investors might be interested in is the one embedded in Streamex’s products: the GLDY stablecoin is structured to provide up to a 4% annual yield paid in gold to token holders (^[6]). However, that yield accrues to token investors, not stockholders, and it will be generated from Streamex’s commodity financing activities (e.g. the discount/interest earned on gold streaming contracts). For equity holders, the potential return hinges on capital appreciation rather than dividends. In summary, Streamex’s dividend policy is to retain all earnings (the company is not yet profitable) – shareholders should not expect any near-term payouts. The current 0% dividend yield reflects that all available capital is being directed toward growth initiatives and establishing the infrastructure for tokenized assets (^[7]).

Leverage, Debt Maturities, and Liquidity

Streamex’s capital structure underwent a major transformation in mid-2025 to support its new business plan. In July 2025, the company (still named BioSig at the time) signed definitive agreements for up to $1.1 billion in growth financing, composed of two key parts: $100 million of senior secured convertible debentures and a $1.0 billion equity line of credit (^[8]) (^[8]). The $100M debentures carry a 4% annual interest rate (stepping up to 18% if an event of default occurs) and a 24-month maturity from issuance (^[8]). These notes are convertible into STEX common shares and are secured by a first-priority lien on certain company assets (^[8]). The associated equity line gives Streamex the right (but not the obligation) to issue and sell up to $1 billion of its stock over a 36-month period to the investor, providing a flexible financing tap (^[8]). Importantly, this equity line requires an effective registration statement to cover resales and was likely structured to fund future asset purchases (e.g. scaling the gold tokenization program) as needed.

The initial funding from this package was scheduled in tranches. The first $75 million of the convertible debentures (out of $100M) was expected to close by early October 2025, pending required shareholder approvals under Nasdaq rules (^[8]). The remaining $25 million of debentures will close at a later date, contingent on certain conditions such as the SEC declaring a resale registration effective (^[8]). Thus, by Q4 2025 Streamex should have received roughly $75M (minus a small OID) in cash from the debentures, significantly bolstering its liquidity. In addition, in August 2025 the company completed a $15 million underwritten equity offering, selling ~3.85 million shares at $3.90 per share (^[9]). This equity raise, which came with no warrants, was explicitly aimed at funding the purchase of physical gold bullion for Streamex’s gold-backed treasury and for general corporate purposes (^[9]). In effect, the August stock issuance immediately supplied capital to start acquiring the gold reserves underlying GLDY, while the larger October debenture financing provides runway for building the platform and funding future tokenized deals.

Leverage: Prior to these financings, Streamex’s balance sheet was very weak – as of June 30, 2025, the combined company had only $2.8 million in cash and a working capital deficit of about $110 million, raising substantial doubt about its ability to continue as a going concern (^[10]). This huge deficit was largely due to accounting for the Streamex reverse merger: as part of the share exchange, Streamex’s former shareholders received exchangeable shares valued at roughly $105 million (reflected as a derivative liability on the books) (^[10]). The infusion of new capital in Q3 2025 has begun to alleviate this strain. The $15M equity injection closed in August and the $75M (initial) debenture funding in October together boost pro forma cash significantly, though it’s worth noting the $75M is debt (convertible) until it potentially turns into equity. On a pro forma basis, assuming $75M in new debt and the post-offering share count (~31.4 million shares as of mid-August (^[10])), Streamex’s debt-to-equity ratio remains high. The $100M convertible equates to over half the company’s current market cap, so Streamex is taking on substantial leverage – albeit with the expectation that this debt will convert into equity if the business executes well. The debentures mature in late 2027, which gives management a two-year window to start generating cash flow or attract equity capital to handle conversion/redemption. There are no other major long-term loans reported, but Streamex does carry legacy liabilities from its pre-transaction operations (e.g. a small amount of preferred stock dividends payable and payables from the BioSig segment (^[10])). Overall, the company’s liquidity position post-financing is improved but still heavily dependent on external funding. Streamex now effectively has a large “war chest” available on paper (the $1B equity line), but tapping that facility would dilute shareholders (see Risks). For now, the near-term cash needs (to launch GLDY and fund initial gold streams) seem covered by the recent ~$90M from the equity and debenture deals. Key debt maturity to watch is 2027 for the convertibles – if Streamex’s share price and market momentum are strong by then, a conversion to equity could occur, but if not, the company might face a hefty repayment or refinancing need within 2 years.

Coverage and Cash Flow

With operations only in their infancy, Streamex’s coverage ratios are currently very weak. The company has generated only minimal revenue to date – approximately $0.2 million in Q1 2025 and similarly low levels in Q2 (^[5]) (^[10]) – while incurring ongoing operating expenses to build out its platform. Streamex reported negative operating cash flow (about $2.4 million net cash used in operations in the first half of 2025) and a net loss exceeding $13 million in that period (^[10]) (^[10]). Given this, any traditional interest coverage metric (EBIT/interest) is essentially zero or negative – the company does not yet earn EBIT to cover its interest obligations. The new $100M convertible debentures will accrue roughly $4 million of interest per year at 4%. At present, that interest must be paid out of Streamex’s cash reserves or future capital raises, since cash flow from operations is insufficient. In fact, management acknowledged in mid-2025 that the low cash balance and lack of revenues “raise substantial doubt” about the company’s ability to continue as a going concern absent new financing (^[10]). The recent financings have addressed the immediate cash crunch, but the coverage of fixed charges remains an area of concern until the business model starts generating steady inflows.

On a positive note, Streamex currently has no dividend or preferred distributions to cover (no cash payouts to equity holders). Also, much of its growth spending (like gold purchases) can be viewed as investment in inventory/treasury rather than operating expense. If GLDY’s launch is successful, Streamex could begin to see revenue streams from origination fees and token spreads in upcoming quarters (^[5]) (^[5]). Those would help offset costs and eventually contribute to interest coverage. However, until such revenue scales up dramatically, coverage ratios will remain very low. It’s fair to say Streamex’s ability to service its obligations hinges on external funding and future performance. The company’s interest coverage and debt service metrics are not at sustainable levels right now – a clear risk for investors to monitor. In summary, Streamex can meet its near-term obligations only thanks to the fresh capital raised; internally generated cash is negligible. This makes execution of the business plan (and timely uptake of the tokenized products) crucial to improving coverage in the next 1-2 years.

Valuation and Comparables

Streamex’s valuation is almost entirely based on future prospects rather than current fundamentals. As of late October 2025, STEX’s stock price hovers around the mid-$5 range, equating to a market capitalization of roughly $180–$190 million (^[11]). This market cap has ballooned in recent months – the stock is up several hundred percent year-to-date – reflecting investor excitement over the company’s pivot to tokenized assets. In conventional terms, Streamex’s valuation multiples are sky-high because current financials are minimal. The company’s trailing twelve-month revenue is only on the order of a few hundred thousand dollars, so its Price/Sales multiple is in the hundreds (if not thousands). It has no positive earnings or cash flow yet, so P/E and EV/EBITDA are not meaningful at this stage. Even on a forward-looking basis, no Wall Street analysts are formally covering STEX (as of now) with estimates, given the nascent and speculative nature of the business model. In essence, the stock’s ~$180M valuation represents investors’ belief in the potential for Streamex to scale up tokenized commodity products and generate significant future revenue/yield – it is not supported by assets or income today.

One way to gauge this potential is to consider analogous markets. For instance, Paxos Gold (PAXG), an established gold-backed crypto token fully collateralized by LBMA vault gold, has an around ~$800 million market cap in circulation (^[5]). Streamex’s GLDY aims to compete in a similar arena (gold on blockchain), but with an added yield component. If GLDY can capture even a fraction of that market, Streamex could oversee hundreds of millions in tokenized assets. Unlike PAXG (which generates limited fees beyond custody), Streamex hopes to earn spreads or origination fees from its structured gold deals – more akin to how gold streaming/royalty companies operate. For context, traditional gold streaming companies (e.g. Franco-Nevada, Wheaton Precious Metals) trade at high multiples of their cash flow (20x+ P/CF), reflecting the attractive economics of upfront financing in exchange for commodity royalties. Streamex is attempting a similar concept but through tokens; if it succeeds, one could imagine revenue ramping up and the market rewarding it with valuation multiples reminiscent of fintech or specialty finance firms.

Don't wait — first dividend checks could arrive any day.

Get the concise guide to start collecting royalty checks now.

Get Instant Access
✕

At present, however, there is significant valuation risk. Streamex’s book value is negligible (shareholders’ equity was about –$3.6M as of Q2 2025 due to merger-related liabilities (^[10]) (^[10]); post financing it might be slightly positive but still small relative to market cap). This means the stock trades at a very large premium to book – essentially valuing intangible factors like the team, the business plan, and first-mover advantage. Another way to frame the valuation is the implied execution: with a ~$180M market cap, investors are implicitly expecting Streamex to deploy the substantial financing available to it and create a profitable tokenized assets franchise. Any shortfall in uptake (e.g. GLDY failing to attract assets, or deals not yielding expected returns) could leave the company’s financials far below what is needed to justify the current valuation. In short, STEX trades on story and potential right now. The upside case (reflected in bullish target prices as high as $10 cited by some sources) assumes Streamex will rapidly grow assets under management and perhaps even tokenization of other commodities or ETFs (^[1]). The downside is that without tangible earnings, the stock could be very volatile and vulnerable to dilution (since raising equity is a core part of the strategy). Until the company delivers consistent results, valuation must be viewed as speculative – traditional metrics aren’t grounded in meaningful data yet.

Risks and Red Flags

Investing in Streamex entails substantial risks, given its early stage and unproven business model. Key risk factors include:

– Regulatory and Compliance Risk: Tokenizing real-world assets, especially with a promised yield, sits in a regulatory gray area. There’s a risk that GLDY or similar tokens could be deemed securities or investment contracts by regulators, bringing them under heavier compliance requirements or even restricting sales to certain investors. Streamex emphasizes that GLDY will be a “regulated, institutional-grade” asset, but it must navigate rules across multiple jurisdictions. For example, handling physical gold involves compliance with London Bullion Market Association (LBMA) standards, anti-money-laundering laws, and other oversight (^[5]). Streamex will need credible custody and audit partners – yet as of late 2025, the company had not yet finalized agreements with LBMA-accredited custodians or vault operators (^[5]). Failure to secure top-tier vaulting could force Streamex to use lesser-known custodians, which “may compromise investor confidence in the underlying gold collateral” (^[5]). In short, the company’s ability to provide the necessary transparency (audits, redemption assurances, etc.) is still an open question. The new Chainlink Proof-of-Reserve feature helps on-chain transparency, but real-world verification (third-party audits of gold bars) must follow. Any regulatory roadblock – whether from securities regulators or commodities regulators – could slow or even derail Streamex’s product rollout.

– Execution and Adoption Risk: Streamex’s entire value proposition hinges on actually launching its tokenization platform and achieving adoption by both asset suppliers (e.g. gold miners or commodity owners) and investors. This is a first-of-its-kind model in public markets – combining aspects of gold streaming financing with blockchain distribution. There’s no guarantee that gold mining companies will prefer Streamex’s tokenized pre-buy contracts over traditional financing. They may be wary of novel arrangements or find Streamex’s terms less attractive than conventional royalty deals (^[5]). Likewise, institutional investors might be cautious to invest in GLDY tokens (especially if they are restricted to accredited investors initially). Competition looms here as well: Paxos’s PAXG and Tether’s XAUT already offer simple gold tokens, and major crypto players are moving into the space – notably, Tether acquired a 32% stake in a gold mining royalties company in 2025 as it explores gold-backed products (^[6]). This means Streamex must compete not only with other startups but with multi-billion-dollar firms in the race to tokenize gold. If GLDY doesn’t offer a compelling advantage (yield alone may be compelling, but it comes with complexity and possibly higher risk), investors could stick with established alternatives. Market acceptance is a significant risk – Streamex needs to build trust and a track record quickly. Any technical glitches in its platform, security breaches, or failure of the token to maintain its gold peg would be major setbacks. Furthermore, convincing investors to value a crypto-token that yields 4% in gold when “risk-free” USD interest rates are ~5% involves a behavioral hurdle – the target clientele must see value in the gold exposure plus blockchain liquidity.

– Dilution and Financing Risk: Streamex’s ambitious growth plans are heavily dependent on external financing, which poses dilution risk. The company has a $1 billion equity line at its disposal – if it were to issue the full amount at today’s roughly ~$5–6 share price, that could imply well over 150 million new shares (on top of ~31 million currently), massively diluting existing holders. Even if issuance is gradual, each draw on the equity line will increase the share count. The $100M convertible debentures will also likely convert to equity if the stock performs; the conversion pricing wasn’t publicly disclosed, but depending on the terms, it could add tens of millions of shares as well (^[8]). There is an inherent financing overhang: investors know that Streamex will need to tap capital markets to fund growth, which can weigh on the stock price. If the share price falls substantially, it could create a vicious cycle (since issuing shares at a lower price would be more dilutive, and a low price could even violate conditions required to use the equity facility or convert the debentures). It’s worth noting that the financing deals themselves carry some red flags typical of micro-cap companies. A huge equity line of credit and a convertible note with a steep default interest rate (18%) are instruments often seen in high-risk capital raises (^[8]). Investors should be alert to any aggressive conversion or share issuance by the financing counterparties – for instance, if the debenture holders rapidly convert and sell shares, it could put downward pressure on STEX’s price (sometimes termed “toxic” financing in extreme cases). Streamex did well to raise cash with no warrants in August, but the sheer scale of planned fundraising is unusual for a company of its size and could be a double-edged sword.

– Corporate Background and Governance: Streamex came to market via a reverse merger with BioSig, a biomedical device firm that had struggled to gain traction. While the rebranding in September 2025 officially shifted BioSig’s identity to Streamex (^[2]), the legacy business (medical device R&D and related subsidiaries) still exists within the company’s structure. This could pose a distraction or a drain on resources. There’s a question of management focus: CEO Henry McPhie was previously BioSig’s CEO and is now steering a very different venture in blockchain finance. The board and management did bring in the Streamex co-founders (McPhie himself is a co-founder of Streamex, and Chairman Morgan Lekstrom comes from a mining background) (^[12]), which provides relevant expertise. Nonetheless, integration risk remains – merging a healthcare tech team with a crypto-finance team is non-trivial, and cultural or strategic misalignment could occur. Another governance concern is the complex share exchange structure: Streamex’s previous owners hold exchangeable shares that convert into common stock upon shareholder approvals (^[5]) (^[5]). The process of obtaining those approvals and the potential dilution from exchanging those shares (over 109 million exchangeable shares were issued (^[5]), tied to BioSig’s stock) is a technical risk factor. While these were accounted as liabilities to avoid “shell company” issues (^[5]), existing shareholders might see additional dilution when the exchangeable shares finally convert into tradable stock. The lack of earnings history, combined with an unconventional merger, could make Streamex’s governance and financial reporting complicated in the near term. Investors should keep an eye on insider ownership and any stock transactions by insiders or large exchangeable shareholders (e.g. lock-up agreements or sales) (^[13]).

In summary, Streamex faces a high-risk, high-reward scenario. The red flags – from going-concern warnings (^[10]), to heavy reliance on future financing, to untested product-market fit – are significant. On the other hand, the upside is that Streamex is operating in a potentially transformative niche at the intersection of traditional commodities and blockchain. The Chainlink partnership and other steps (like S&P index inclusion and strategic advisors appointments) lend some credibility, but execution will ultimately determine if these risks are overcome.

Open Questions and Outlook

Given Streamex’s early stage, several open questions remain about its trajectory:

– Will the GLDY launch succeed? The company is in the process of launching GLDY via a $100 million institutional pre-sale (set for Nov. 10, 2025) targeting accredited investors (^[6]). This raise is essentially a critical market test for Streamex’s concept. A successful full subscription (or close to it) would validate strong demand for a gold-backed, yield-bearing token and provide Streamex with fee income and AUM to manage. If the pre-sale falls short, it may signal lukewarm interest and could constrain Streamex’s ability to generate revenue. Investors will be watching: How many assets does GLDY attract, and at what pace? Additionally, once GLDY is active, how will the 4% yield be sustained? Streamex will need to demonstrate the mechanics of paying yield in gold – presumably through the returns from its streaming contracts or other gold investments. An open question is whether those financing deals with miners will indeed produce the necessary yield (and what happens if gold prices or mining outputs don’t meet expectations). Essentially, can Streamex reliably deliver the promised yield without eroding its own capital?

– How quickly can revenue scale? Streamex’s current revenues are trivial (few hundred thousand dollars), but its expenses – and now interest costs – are mounting. The company has outlined multiple potential revenue streams (origination fees on tokenized deals, listing and trading fees, liquidity spreads, etc.) (^[5]). A key question is when will these start to materialize and in what magnitude? For example, if GLDY raises $100M and charges even a modest annual management or structuring fee, that could start to bring in meaningful revenue. The LOI with Simplify Asset Management hints at future products (like tokenized ETF strategies) (^[1]), which could open new revenue avenues, but timing is uncertain. Until we see quarterly results post-GLDY launch, investors won’t know if Streamex is on track to, say, millions in revenue by 2026 or still stuck in pilot-scale volumes. Achieving scale is an open challenge: the company’s own pro forma projections (mentioning ~53% annual revenue growth through 2030 in valuation analyses (^[10])) are ambitious. Will Streamex secure enough deals with commodity producers and enough investor participation to grow at such a clip? This will be answered only as the platform rolls out.

– What is the fate of Streamex’s non-tokenization assets? Upon merging, Streamex inherited BioSig’s legacy businesses (medical device R&D and related ventures). Management’s attention is now clearly on the tokenization side, so an open question is how they will handle the legacy healthcare segment. Will it be sold, spun-off, or wound down? As of mid-2025, BioSig’s PURE EP medical device platform and its minority interests in biotech subsidiaries remained on the books (^[10]). These could potentially be monetized or divested, which might bring in some cash or at least remove a cash burn. Alternatively, Streamex might choose to retain them, but that seems unlikely given the strategic focus. Clarity on this issue is pending – investors should watch for any announcements regarding the disposition of legacy assets or a further restructuring to become a pure-play fintech/tokenization firm. The resolution of this will affect Streamex’s cost structure and focus; eliminating the non-core projects could improve the company’s cash burn and management bandwidth.

– How will dilution be managed? While the financing deals provide capital, shareholder dilution is a looming question. Streamex’s management will have to balance the use of the $1B equity line and convertible conversions with market conditions. An open question is: will the company attempt to uplift its stock price (through delivering results or strategic partnerships) before drawing heavily on the equity line, thereby minimizing dilution? Or will it draw incrementally regardless of share price? The answer will impact shareholder value. Another unknown is the exact terms of conversion for the debentures – if the conversion price is floating or at a discount, that could incentivize the debtholders to convert and sell quickly. Streamex has not publicly detailed these terms, so investors are left to guess the dilution trajectory. The outcome of the shareholder vote on the financing (required by Nasdaq for large issuances) is another point – although it’s likely to pass given the need for capital, any significant investor pushback would be noteworthy. In short, capital management strategy remains to be seen in practice.

– Competitive and technological trajectory: Longer term, there are open questions about how Streamex positions itself in the evolving tokenization industry. The partnership with Chainlink is a big step, but will Streamex form other key partnerships (for instance, with major exchanges, broker-dealers, or custodians) to drive adoption? Also, how will regulators react as the company’s products reach the market? Positive regulatory developments (like clearer rules for tokenized assets or endorsements from bodies like the SEC/CFTC for certain structures) could accelerate Streamex’s growth, whereas adverse developments (e.g. restrictive legislation or enforcement actions in the broader crypto sector) could pose hurdles. Additionally, scalability is a question: if Streamex were to handle, say, a billion dollars of tokenized commodities, can its infrastructure (both technical and operational) support that volume? These technical and market strategy questions will only be answered as the company progresses.

In conclusion, Streamex (STEX) has made bold moves to position itself at the forefront of asset tokenization, and its Chainlink partnership underscores the seriousness of its intent to provide a secure, transparent platform. The coming quarters will be pivotal in determining whether this ambitious venture can gain traction. Investors should keep a close eye on GLDY’s market reception, the execution of streaming deals, and the financial discipline of management in deploying capital. If Streamex delivers on its promises, it could indeed be a game-changer in tokenizing commodities – but for now, it remains a high-risk story stock with much to prove.

Sources:

– Streamex Corp. press release on Chainlink partnership (Oct 27, 2025) – GlobeNewswire (^[4]) (^[4]) – Streamex Corp. / BioSig Technologies corporate rebranding announcement (Sept 2025) – GlobeNewswire (^[2]) – Streamex business overview (Investor Relations site) (^[1]); Company description of GLDY token (^[3]) (^[3]) – Dividend policy: Streamex does not pay a dividend (^[7]). Seeking Alpha dividend scorecard. – Financing agreements: BioSig/Streamex press release on $1.1B financing (July 7, 2025) – BusinessWire (^[8]) (^[8]). Details on convertible debentures and equity line. – Equity offering: BioSig/Streamex press release on $15M public offering pricing (Aug 13, 2025) (^[9]). Use of proceeds for gold purchases. – Q2 2025 10-Q (BioSig/Streamex) – liquidity and going concern disclosure (^[10]); financial condition and derivative liability (^[10]); minimal revenue and early-stage risks (^[10]). – Streamex initial revenue (pre-merger Q1 2025) – Company filing (^[5]). – Competitive landscape: Streamex SEC filing (Ex.99.1) citing Paxos’ gold token (~$810M market cap) and Securitize’s tokenized assets (^[5]). – Regulatory/custody risks: Streamex risk factors on need for LBMA-accredited vaults and execution of agreements (^[5]) (^[5]). – Stablecoin launch news: Cointelegraph – Streamex stock surge on GLDY pre-sale (Oct 2025) (^[6]) (^[6]); GLDY details (4% yield, Nov 10 launch) (^[6]). – Macro trends: Cointelegraph – context on Tether and gold tokenization moves (^[6]). – Simplify Asset Management LOI: Streamex IR release (Sept 17, 2025) (^[1]). – Index inclusion: S&P Dow Jones Indices – Streamex added to Global BMI (Sept 2025) (^[14]) (indicative of increased visibility). – Additional financial data from MarketScreener, TradingView, etc., for market cap and share price history (^[11]).

Sources

1. https://ir.streamex.com/
2. https://ir.biosig.com/press-releases/detail/386/biosig-technologies-inc-announces-corporate-rebrand-to
3. https://globenewswire.com/news-release/2025/10/28/3175062/22558/en/Streamex-Corp-NASDAQ-STEX-Enters-Strategic-Partnership-with-Chainlink-as-Its-Official-Oracle-Provider-to-Strengthen-Tokenization-Infrastructure.html
4. https://markets.financialcontent.com/stocks/article/gnwcq-2025-10-28-streamex-corp-nasdaq-stex-enters-strategic-partnership-with-chainlink-as-its-official-oracle-provider-to-strengthen-tokenization-infrastructure
5. https://ir.biosig.com/all-sec-filings/content/0001641172-25-020308/ex99-1.htm
6. https://cointelegraph.com/news/streamex-shares-soar-gold-backed-stablecoin
7. https://seekingalpha.com/symbol/STEX/dividends/scorecard
8. https://ir.biosig.com/news/detail/376/biosig-technologies-inc-and-streamex-exchange-corporation-announce-definitive-agreements-for-up-to-1-1b-usd-in-growth-financing-to-launch-gold-backed-treasury-management-strategy-and-to-rapidly-expand-rwa-tokenization-for-the-commodities-markets
9. https://biosig.com/news-media/press-releases/detail/381/biosig-technologies-inc-announces-pricing-of-15-million
10. https://otcmarkets.com/filing/html?guid=BkZ-k6RzK-SZdth&%3Bid=18703985
11. https://marketxls.com/stocks/STEX/dividends
12. https://biosig.com/news-media/press-releases/detail/371/streamex-and-biosig-announce-the-successful-closing-of
13. https://quiverquant.com/news/Streamex%2BPartners%2Bwith%2BChainlink%2Bto%2BEnhance%2BCross-Chain%2BFunctionality%2Band%2BTransparency%2Bfor%2BGLDY%2BStablecoin
14. https://marketscreener.com/quote/stock/STREAMEX-CORP-46321442/calendar/

For informational purposes only; not investment advice.